Commentary
This retrospective cross-sectional study was conducted among patients recruited from a large, community-based hospital system’s outpatient liver clinic from 2001 to 202 in order to determine the performance of the enhanced liver fibrosis (ELF) test as a non-invasive test for assessment of liver fibrosis among patients with NAFLD. The findings of this study suggest that the ELF test allows an early recognition of liver fibrosis in patients with NAFLD. This test combined with fib-4 score may be reliably used in clinical practice to assess the presence or absence of advanced fibrosis among patients with NAFLD.
Previous Post
Phytomedicines in experimental models of NAFLD
Next Post
Serum uric acid level and NAFLD in T2DM patients